SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-16-625139
Filing Date
2016-06-17
Accepted
2016-06-17 17:14:01
Documents
68
Period of Report
2016-03-22
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 8-K d212391d8ka.htm 8-K/A 20056
2 EX-23.1 d212391dex231.htm EX-23.1 1649
3 EX-99.2 d212391dex992.htm EX-99.2 280843
  Complete submission text file 0001193125-16-625139.txt   3641338

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT eigr-20151231.xml EX-101.INS 597399
5 XBRL TAXONOMY EXTENSION SCHEMA eigr-20151231.xsd EX-101.SCH 56377
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eigr-20151231_cal.xml EX-101.CAL 54310
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eigr-20151231_def.xml EX-101.DEF 213969
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigr-20151231_lab.xml EX-101.LAB 433442
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigr-20151231_pre.xml EX-101.PRE 336150
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36183 | Film No.: 161720848
SIC: 2836 Biological Products, (No Diagnostic Substances)